Wellington Management Group LLP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 09:27 am Sale | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | Wellington Management Group LLP | 1,638,273 1.610% | -5,297,641 (-76.38%) | Filing |
| 2021-02-04 11:27 am Purchase | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | Wellington Management Group LLP | 6,935,914 7.630% | 2,344,285 (+51.06%) | Filing |